Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (21-30 of 373) with videos related to

Pageof 38
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
In Vivo Myeloperoxidase Imaging and Flow Cytometry Analysis of Intestinal Myeloid CellsJan Hülsdünker, Robert Zeiser
Blood|July 19, 2023
The role of the MDM2/p53 axis in antitumor immune responsesTilman Brummer, Robert Zeiser
Frontiers in Immunology|February 2, 2019
Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHDNatalie Köhler, Robert Zeiser
Journal of Biomedicine & Biotechnology|November 6, 2012
Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantationPetya Chernogorova, Robert Zeiser
Best Practice & Research. Clinical Haematology|October 13, 2024
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host diseaseValentin Wenger, Robert Zeiser
Frontiers in Immunology|October 5, 2020
Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell TransplantationSophia Chen, Robert Zeiser
The Lancet. Respiratory Medicine|February 6, 2022
Baricitinib for patients with severe COVID-19-time to change the standard of care?Alexander Supady, Robert Zeiser
International Journal of Hematology|April 23, 2022
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantationFrancesca Biavasco, Robert Zeiser
Blood Advances|August 12, 2020
The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host diseaseRobert Zeiser, Gérard Socié
Blood|September 5, 2021
Nonclassical manifestations of acute GVHDRobert Zeiser, Takanori Teshima
Pageof 38

Showing results (21-30 of 373) with videos related to

Sort By:
Pageof 38
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
In Vivo Myeloperoxidase Imaging and Flow Cytometry Analysis of Intestinal Myeloid CellsJan Hülsdünker, Robert Zeiser
Blood|July 19, 2023
The role of the MDM2/p53 axis in antitumor immune responsesTilman Brummer, Robert Zeiser
Frontiers in Immunology|February 2, 2019
Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHDNatalie Köhler, Robert Zeiser
Journal of Biomedicine & Biotechnology|November 6, 2012
Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantationPetya Chernogorova, Robert Zeiser
Best Practice & Research. Clinical Haematology|October 13, 2024
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host diseaseValentin Wenger, Robert Zeiser
Frontiers in Immunology|October 5, 2020
Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell TransplantationSophia Chen, Robert Zeiser
The Lancet. Respiratory Medicine|February 6, 2022
Baricitinib for patients with severe COVID-19-time to change the standard of care?Alexander Supady, Robert Zeiser
International Journal of Hematology|April 23, 2022
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantationFrancesca Biavasco, Robert Zeiser
Blood Advances|August 12, 2020
The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host diseaseRobert Zeiser, Gérard Socié
Blood|September 5, 2021
Nonclassical manifestations of acute GVHDRobert Zeiser, Takanori Teshima
Pageof 38